Aminocaproic Acid Injection, Solution
Product Images NDC 0409-4346

3 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aminocaproic Acid (NDC 0409-4346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Aminocaproic 01)

FDA Label Image

Principal Display Panel (5 g/20 mL Vial Label)

Principal Display Panel (5 g/20 mL Vial Label)
Label for AMINOCAPROIC ACID Injection, USP, 5 g/20 mL (250 mg/mL) in a 20 mL single-dose vial. The label includes a caution that the product must be diluted for intravenous use. Distributed by Hospira, Inc. The label also notes that each mL contains 250 mg of aminocaproic acid and may include hydrochloric acid for pH adjustment.*
FDA Label Image

Principal Display Panel (5 g/20 mL Vial Tray)

Principal Display Panel (5 g/20 mL Vial Tray)
Packaging label for AMINOCAPROIC ACID Injection, USP by Hospira, Inc., containing 25 single-dose vials of 20 mL each. The strength is 5 g/20 mL (250 mg/mL). The label includes usage instructions, caution that the product must be diluted for intravenous use, and storage information. The labeler is Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.